113 related articles for article (PubMed ID: 20622519)
21. Assessment of the perceptions and administration of the human papillomavirus vaccine.
Schnatz PF; Humphrey K; O'Sullivan DM
J Low Genit Tract Dis; 2010 Apr; 14(2):103-7. PubMed ID: 20354417
[TBL] [Abstract][Full Text] [Related]
22. HPV vaccination in Italy: perspectives after 1-year experience.
Icardi G
J Prev Med Hyg; 2008 Dec; 49(4):125-8. PubMed ID: 19350958
[No Abstract] [Full Text] [Related]
23. Human papillomavirus vaccination uptake and factors related to uptake in a traditional desert city in the United Arab Emirates.
Al-Nuaimi NS; Al-Ghas YS; Al-Owais AH; Grivna M; Schneider J; Nagelkerke NJ; Bernsen RM
Int J STD AIDS; 2011 Jul; 22(7):400-4. PubMed ID: 21729960
[TBL] [Abstract][Full Text] [Related]
24. Approaches to monitoring biological outcomes for HPV vaccination: challenges of early adopter countries.
Wong CA; Saraiya M; Hariri S; Eckert L; Howlett RI; Markowitz LE; Brotherton JM; Sinka K; Martinez-Montañez OG; Kjaer SK; Dunne EF
Vaccine; 2011 Jan; 29(5):878-85. PubMed ID: 20971113
[TBL] [Abstract][Full Text] [Related]
25. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP).
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 May; 59(20):626-9. PubMed ID: 20508593
[TBL] [Abstract][Full Text] [Related]
26. Physician attitudes and practice toward human papillomavirus vaccination.
Ko EM; Missmer S; Johnson NR
J Low Genit Tract Dis; 2010 Oct; 14(4):339-45. PubMed ID: 20885162
[TBL] [Abstract][Full Text] [Related]
27. HPV vaccine and males: issues and challenges.
Zimet GD; Rosenthal SL
Gynecol Oncol; 2010 May; 117(2 Suppl):S26-31. PubMed ID: 20129653
[TBL] [Abstract][Full Text] [Related]
28. Influence of patient's relationship status and HPV history on physicians' decisions to recommend HPV vaccination.
Zimet GD; Stupiansky NW; Weiss TW; Rosenthal SL; Good MB; Vichnin MD
Vaccine; 2011 Jan; 29(3):378-81. PubMed ID: 21111781
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus vaccine acceptability among young adult men.
Gerend MA; Barley J
Sex Transm Dis; 2009 Jan; 36(1):58-62. PubMed ID: 18830138
[TBL] [Abstract][Full Text] [Related]
30. Practical implementation of HPV vaccines in clinical practice.
Kimmel SR
J Fam Pract; 2006 Nov; Suppl():18-22. PubMed ID: 17366754
[TBL] [Abstract][Full Text] [Related]
31. Programmatic issues in the implementation of an HPV vaccination program to prevent cervical cancer.
Ault K; Reisinger K
Int J Infect Dis; 2007 Nov; 11 Suppl 2():S26-8. PubMed ID: 18162242
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus vaccine: widening the scope for cancer prevention.
No JH; Kim MK; Jeon YT; Kim YB; Song YS
Mol Carcinog; 2011 Apr; 50(4):244-53. PubMed ID: 21465574
[TBL] [Abstract][Full Text] [Related]
33. Preventive and therapeutic HPV vaccines.
Monie A; Hung CF; Wu TC
Curr Opin Investig Drugs; 2007 Dec; 8(12):1038-50. PubMed ID: 18058574
[TBL] [Abstract][Full Text] [Related]
34. "Is cancer contagious?": Australian adolescent girls and their parents: making the most of limited information about HPV and HPV vaccination.
Cooper Robbins SC; Bernard D; McCaffery K; Brotherton J; Garland S; Skinner SR
Vaccine; 2010 Apr; 28(19):3398-408. PubMed ID: 20199758
[TBL] [Abstract][Full Text] [Related]
35. Introducing human papillomavirus vaccines - questions remain.
Paavonen J; Lehtinen M
Ann Med; 2008; 40(3):162-6. PubMed ID: 18382882
[TBL] [Abstract][Full Text] [Related]
36. The attitudes of Australian gynaecologists to HPV vaccination: an ASCCP survey.
Tan J; Farrell L; Allen DG
Aust N Z J Obstet Gynaecol; 2010 Oct; 50(5):472-7. PubMed ID: 21039383
[TBL] [Abstract][Full Text] [Related]
37. Girls' preferences for HPV vaccination: a discrete choice experiment.
de Bekker-Grob EW; Hofman R; Donkers B; van Ballegooijen M; Helmerhorst TJ; Raat H; Korfage IJ
Vaccine; 2010 Sep; 28(41):6692-7. PubMed ID: 20708696
[TBL] [Abstract][Full Text] [Related]
38. Social disparity potentially revealed in parental perceptions of HPV vaccine.
Rees J
Expert Rev Vaccines; 2013 Jul; 12(7):721. PubMed ID: 24046853
[No Abstract] [Full Text] [Related]
39. Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine.
Olsson SE; Villa LL; Costa RL; Petta CA; Andrade RP; Malm C; Iversen OE; Høye J; Steinwall M; Riis-Johannessen G; Andersson-Ellstrom A; Elfgren K; von Krogh G; Lehtinen M; Paavonen J; Tamms GM; Giacoletti K; Lupinacci L; Esser MT; Vuocolo SC; Saah AJ; Barr E
Vaccine; 2007 Jun; 25(26):4931-9. PubMed ID: 17499406
[TBL] [Abstract][Full Text] [Related]
40. [HPV vaccination: principles, results and future perspectives].
Rouzier R; Uzan C; Collinet P
J Gynecol Obstet Biol Reprod (Paris); 2007 Feb; 36(1):13-8. PubMed ID: 17293248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
